Blood and tissue tests to predict endometrial cancer recurrence

Researchers at M.D. Anderson Cancer Center are studying whether simple blood tests can help predict which patients with endometrial cancer are at higher risk of their cancer returning after treatment. The study collects blood samples at different points during your care—before surgery, after surgery, and after chemotherapy—along with tissue samples from surgery. By comparing genetic information found in your blood to the actual tumor tissue, the researchers hope to develop a better way to identify patients who need closer monitoring or more aggressive treatment.

Right now, doctors don't have a reliable way to know which endometrial cancer patients will have their cancer come back after treatment. This study aims to fill that gap by testing whether genetic markers found in blood samples—called 'liquid biopsies'—could serve as an early warning sign of recurrence, potentially helping doctors intervene sooner.